News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

China Cord Blood Corporation Announces $65 Million Investment from Kohlberg Kravis Roberts & Co. L.P.


4/13/2012 12:22:39 PM

April 13, 2012 --China Cord Blood Corp., the largest operator of cord blood banks in China, raised $65 million in new cash from Kohlberg Kravis Roberts. KKR made the investment through its China Growth Fund LLP, which bought $65 million of 5-year convertible bonds. It is the fund's first healthcare investment. The bonds pay 7% face amount, though other conditions can increase that rate, and they convert into common stock at roughly today's market price. More details....

Stock Symbol: (NYSE: CO)


Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES